What clinical criteria and tests are required to declare brain death?

Brain Death Declaration: Clinical Criteria and Testing Requirements

Brain death determination is a clinical diagnosis based on the irreversible cessation of all brain function, requiring two separate examinations by different attending physicians, demonstration of coma with absent brainstem reflexes, and a positive apnea test showing PaCO2 ≥60 mm Hg with ≥20 mm Hg rise above baseline without respiratory effort. 1

Prerequisites Before Initiating Brain Death Evaluation

Before any brain death examination can begin, you must correct all confounding factors that could interfere with the neurologic assessment:

Physiologic Stabilization Required

• Correct hypotension, hypothermia (core temperature must be >35°C), and all metabolic disturbances (including severe electrolyte abnormalities, acid-base disorders, and endocrine dysfunction) 1
• Ensure hemodynamic stability with blood pressure appropriate for the patient's age 1

Medication Clearance

• Discontinue all sedatives, analgesics, neuromuscular blockers, and anticonvulsants for adequate time based on elimination half-lives 1
• Document total cumulative doses (mg/kg) of all sedating medications since hospital admission 1
• Do not proceed with brain death determination if supratherapeutic or high therapeutic levels of sedative agents are present 1
• When levels are low-to-mid therapeutic range, medication effects are unlikely to confound the examination 1
• If uncertainty about medication effects remains, perform an ancillary study 1

Common pitfall: Phenobarbital has extremely long half-lives (20-133 hours in infants, 45-500 hours in neonates), and pentobarbital persists for 25 hours—wait appropriately or obtain drug levels 1

Timing Considerations

• Defer evaluation for 24-48 hours or longer after cardiopulmonary resuscitation or severe acute brain injury if concerns or inconsistencies exist in the examination 1
• Establish a known irreversible neurologic diagnosis that can lead to complete loss of all brain function 1

Clinical Examination Components

The neurologic examination must demonstrate complete absence of all brain function:

1. Coma Assessment

• No evidence of arousal or awareness to maximal external stimulation, including noxious visual, auditory, and tactile stimulation 2
• Complete absence of any response to painful stimulation 1

2. Brainstem Reflex Testing

Pupillary reflexes:

• Pupils must be fixed in midsize or dilated position (4-9 mm) and completely nonreactive to bright light 1, 2

Corneal reflexes:

• Absent corneal reflex demonstrated by touching the cornea with tissue paper, cotton swab, or water squirts with no eyelid movement 1, 2
• Take care not to damage the cornea during testing 1

Oculocephalic reflexes (Doll's eyes):

• Absent eye movement when head is turned rapidly side to side (only if cervical spine integrity confirmed) 1

Oculovestibular reflexes (Cold caloric testing):

• Confirm external auditory canal patency first 1
• Elevate head to 30 degrees 1
• Irrigate each ear separately with 10-50 mL ice water 1
• No eye movement should occur during 1 minute of observation 1
• Test both sides with several minutes interval between 1

Facial movement:

• No facial muscle response to noxious stimulation of face, including supraorbital pressure 1, 2

Gag reflex:

• Absent to bilateral posterior pharyngeal stimulation 1, 2

Cough reflex:

• Absent to deep tracheal suctioning with 1-2 suctioning passes 1, 2

3. Motor Response Assessment

• Flaccid tone and complete absence of spontaneous or induced movements to noxious stimulation of all limbs 1, 2
• Spinal cord reflexes (reflex withdrawal, spinal myoclonus) may be present and do not preclude brain death diagnosis 1
• Evaluate tone by passive range of motion 1

Apnea Testing Protocol

This is the most critical confirmatory test and must be performed safely:

Pre-test Requirements

• Normalize pH and PaCO2 by arterial blood gas 1
• Maintain core temperature >35°C 1
• Normalize blood pressure for patient's age 1
• Preoxygenate with 100% oxygen for 5-10 minutes 1

Testing Procedure

• Disconnect from mechanical ventilation once well-oxygenated and normal PaCO2 achieved 1
• Continuously monitor heart rate, blood pressure, and oxygen saturation 1
• Observe for any spontaneous respiratory effort throughout entire procedure 1
• Obtain follow-up blood gases to monitor PaCO2 rise 1

Positive Test Criteria (Consistent with Brain Death)

• No respiratory effort observed when PaCO2 ≥60 mm Hg AND ≥20 mm Hg above baseline, with pH <7.30 1, 2
• For patients with chronic respiratory disease responsive only to supranormal PaCO2, ensure ≥20 mm Hg rise above their baseline 1

Abort Testing If:

• Oxygen saturation falls below 85% 1
• Hemodynamic instability occurs 1
• Unable to achieve PaCO2 ≥60 mm Hg 1
• Any evidence of respiratory effort is inconsistent with brain death—terminate test immediately 1

If apnea test cannot be completed safely, an ancillary study must be performed 1

Number of Examinations and Observation Periods

Examination Requirements

• Two complete examinations including apnea testing, each separated by an observation period, are required 1
• Examinations must be performed by different attending physicians involved in the patient's care 1
• The same physician (preferably the attending managing ventilator care) may perform both apnea tests 1
• Examinations should be performed by experienced clinicians with specific training in neurocritical care 1

Observation Periods (Pediatric-Specific)

• 24 hours for neonates (37 weeks gestation to 30 days of age) 1
• 12 hours for infants and children (>30 days to 18 years) 1

Note: The provided guidelines are pediatric-focused; adult protocols typically do not mandate specific observation periods between examinations, though institutional policies vary 2, 3

Purpose of Each Examination

• First examination determines the patient has met neurologic criteria for brain death 1
• Second examination confirms brain death based on unchanged and irreversible condition 1

Ancillary Studies

When Ancillary Studies Are Indicated

Ancillary studies (EEG and radionuclide cerebral blood flow) are NOT required to establish brain death unless: 1

1. Components of clinical examination or apnea testing cannot be completed safely due to underlying medical condition 1
2. Uncertainty exists about neurologic examination results 1
3. Medication effects may interfere with evaluation 1
4. To reduce the inter-examination observation period 1

Critical Limitations

• Ancillary studies are NOT a substitute for the neurologic examination 1
• When used to reduce observation period, all aspects of examination and apnea testing must still be completed and documented 1
• When used due to examination limitations, complete all components that can be safely performed 1

If Ancillary Study Is Equivocal

• Patient cannot be pronounced dead 1
• Continue observation until brain death can be declared on clinical criteria and apnea testing 1
• Wait 24 hours before repeat clinical reevaluation or repeat ancillary study 1
• Continue supportive care during this period 1

Declaration of Death

Death is declared after confirmation and completion of the second clinical examination and apnea test 1

Documentation Requirements

• When ancillary studies are used, document all components of the second clinical examination that could be completed, which must remain consistent with brain death 1
• All aspects of clinical examination, apnea test, or ancillary studies must be appropriately documented 1

Family Communication

• Use clear, concise, simple terminology so families understand their loved one has died 1
• Consider permitting families to be present during brain death examination, apnea testing, and ancillary studies to help them understand death has occurred 1
• Once brain death is declared, the patient meets legal criteria for death—do not discuss "withdrawal of support" as this confuses families 1
• Make clear that continuation of medical therapies including ventilator support is no longer an option unless organ donation is planned 1

Special Populations and Circumstances

Extracorporeal Membrane Oxygenation (ECMO)

• Brain death determination is possible on ECMO but requires special considerations for apnea testing 2, 4
• Consult updated guidelines for specific ECMO protocols 2

Therapeutic Hypothermia/Targeted Temperature Management

• Brain death determination after therapeutic hypothermia requires additional precautions 2, 4
• Ensure adequate rewarming and medication clearance 2

Pediatric Considerations

• Do not apply these criteria to preterm infants <37 weeks gestational age—insufficient data exists 1
• Longer observation periods required for neonates reflect developmental considerations 1, 5

Common pitfall: Failing to wait adequate observation periods in pediatric patients or proceeding with determination too soon after cardiopulmonary resuscitation can lead to diagnostic error 1, 5